You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

309 Results
Drug
Other Name(s): Tasigna®
Quick Link(s): Drug Monograph, Patient Info Sheet
Dec 2023
Drug
Other Name(s): Trelstar® (Allergan Pharma)
Quick Link(s): Drug Monograph, Patient Info Sheet
Oct 2014
Drug
Other Name(s): Vesanoid®
Quick Link(s): Drug Monograph, Patient Info Sheet
Jun 2019
Drug
Other Name(s): Thalomid®
Quick Link(s): Drug Monograph, Patient Info Sheet
Jun 2019
Drug
Other Name(s): Nolvadex®-D
Quick Link(s): Drug Monograph, Patient Info Sheet
May 2022
Drug
Other Name(s): Lanvis®
Quick Link(s): Drug Monograph, Patient Info Sheet
Jun 2019
Drug
Other Name(s): Hycamtin®
Quick Link(s): Drug Monograph, Patient Info Sheet
Apr 2023
Drug
Other Name(s): Torisel ®
Quick Link(s): Drug Monograph, Patient Info Sheet
Jun 2024
Drug
Other Name(s): Atriance®
Quick Link(s): Drug Monograph, Patient Info Sheet
Apr 2024
Regimen
Cancer Type:
Genitourinary, 
Renal cell / Kidney
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Funding:
New Drug Funding Program
    Temsirolimus - Metastatic Renal Cell Carcinoma
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
temsirolimus
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Jun 2024
Regimen
Cancer Type:
Skin, 
Melanoma
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Funding:
ODB - General Benefit
    temozolomide
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
temozolomide
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Jun 2021
Regimen
Cancer Type:
Breast
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Funding:
New Drug Funding Program
    Nab-Paclitaxel - Metastatic Breast Cancer
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
nab-PACLitaxel
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Nov 2023

Pages